INEO
INNEOVA Holdings Ltd
$0.5360
-2.55%
$8.7M
No data for this timeframe.
Vol
Market Cap$8.7M
Cap SizeNano Cap
SEC Reports2
Exchange Nasdaq·Sector Wholesale-Motor Vehicles & Motor Vehicle Parts & Supplies·Inc. E9·CIK 0001933951·Prev Close $0.5500
Recent Activity
Jun 5, 2026
SEC
INNEOVA Holdings filed an unaudited interim balance sheet as of March 31, 2026, showing total assets of $50.3M (up 21% f
6-K — Impact 5/10
May 15, 2026
SEC
INNEOVA Holdings filed its FY2025 20-F, reporting a net loss of $0.4M vs net income of $0.4M in FY2024, driven by a 6.9%
20-F — Impact 6/10
Latest Reports
BEARISH
6-K
5/10
INNEOVA Holdings filed an unaudited interim balance sheet as of March 31, 2026, showing total assets of $50.3M (up 21% f
Jun 5, 2026
BEARISH
20-F
6/10
INNEOVA Holdings filed its FY2025 20-F, reporting a net loss of $0.4M vs net income of $0.4M in FY2024, driven by a 6.9%
May 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 5.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.